About BPC-157
BPC-157 is a synthetic 15�amino acid peptide commonly referenced as Body Protection Compound, derived from a peptide sequence identified in gastric juice. It is supplied as a lyophilized powder for laboratory research investigating cellular signaling, stress-response pathways, and tissue repair�associated mechanisms in controlled experimental models. Each batch is verified for identity and purity using analytical techniques such as HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis.
Recent research on BPC-157: Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis.
Read Full Study on PubMedHuman evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety.
Recent research on BPC-157: Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety.
Read Full Study on PubMedAdditional Studies
BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence.
Recent research on BPC-157: BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence.
Read on PubMedFabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.
Recent research on BPC-157: Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.
Read on PubMedStable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats.
Recent research on BPC-157: Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats.
Read on PubMedUnilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.
Recent research on BPC-157: Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.
Read on PubMedRelated Research
Purchase BPC-157 from Keystone Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.